Ewa Gatlik, Beata Mehes, Emilie Voltz, Ulrike Sommer, Elaine Tritto, Giulia Lestini, . . . Guido Junge. (2024). First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor. Wiley.
Chicago Style (17th ed.) CitationEwa Gatlik, et al. First‐in‐human Safety, Tolerability, and Pharmacokinetic Results of DFV890, an Oral Low‐molecular‐weight NLRP3 Inhibitor. Wiley, 2024.
MLA (9th ed.) CitationEwa Gatlik, et al. First‐in‐human Safety, Tolerability, and Pharmacokinetic Results of DFV890, an Oral Low‐molecular‐weight NLRP3 Inhibitor. Wiley, 2024.
Warning: These citations may not always be 100% accurate.